Skip to main content

Therapeutic Strategy for PBM Without Biliary Dilatation

  • Chapter
  • First Online:
Pancreaticobiliary Maljunction and Congenital Biliary Dilatation

Abstract

Pancreaticobiliary maljunction (PBM) describes both cases in which the extrahepatic bile duct is dilated (PBM with biliary dilatation, congenital biliary dilatation) and those in which it is not dilated (PBM without biliary dilatation). A recent detailed report of extrahepatic bile duct measurements using ultrasonography has largely defined a non-dilated bile duct. According to the report, the maximum inner diameter of an extrahepatic bile duct increases according to age. Once the diagnosis of PBM is established, immediate prophylactic surgical treatment is recommended before the onset of malignant changes, even in patients without biliary dilatation. Cholecystectomy and resection of the extrahepatic bile duct, so-called flow-diversion surgery, are established standard surgical methods for PBM with biliary dilatation. As a therapeutic strategy for PBM without biliary dilatation, prophylactic cholecystectomy is also strongly recommended as standard surgical treatment for prevention of gallbladder cancer. However, whether additional prophylactic resection of the extrahepatic bile duct, as in flow-diversion surgery, should be performed for PBM without biliary dilatation remains controversial. Further investigation and surveillance are needed to clarify the appropriate surgical strategy for PBM without biliary dilatation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Takuma K, Kamisawa T, Tabata T, Hara S, Kuruma S, Inaba Y, et al. Importance of early diagnosis of pancreaticobiliary maljunction without biliary dilatation. World J Gastroenterol. 2012;18:3409–14.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kamisawa T, Ando H, Hamada Y, Fujii H, Koshinaga T, Urushihara N, et al. Diagnostic criteria for pancreaticobiliary maljunction 2013. J Hepatobiliary Pancreat Sci. 2014;21:159–61.

    Article  PubMed  Google Scholar 

  3. Itoi T, Kamisawa T, Fujii H, Inui K, Maguchi H, Hamada Y, et al. Extrahepatic bile duct measurement by using transabdominal ultrasound in Japanese adults: multi-center prospective study. J Gastroenterol. 2013;48:1045–50.

    Article  PubMed  Google Scholar 

  4. Kamisawa T, Kuruma S, Chiba K, Tabata T, Koizumi S, Kikuyama M. Biliary carcinogenesis in pancreaticobiliary maljunction. J Gastroenterol. 2017;52:158–63.

    Article  CAS  PubMed  Google Scholar 

  5. Morine Y, Shimada M, Takamatsu H, Araida T, Endo I, Kubota M, et al. Clinical features of Pancreaticobiliary Maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat Sci. 2013;20:472–80.

    Article  PubMed  Google Scholar 

  6. Noda Y, Fujita N, Kobayashi G, Ito K, Horaguchi J, Takasawa O, et al. Histological study of gallbladder and bile duct epithelia in patients with anomalous arrangement of the pancreaticobiliary ductal system: comparison between those with and without a dilated common bile duct. J Gastroenterol. 2007;42:211–8.

    Article  PubMed  Google Scholar 

  7. Masuhara S, Kasuya K, Aoki T, Yoshimatsu A, Tsuchida A, Koyanagi Y. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction. J Hepato-Biliary-Pancreat Surg. 2000;7:198–205.

    Article  CAS  Google Scholar 

  8. Deng YL, Cheng NS, Lin YX, Zhou RX, Yang C, Jin YW, et al. Relationship between pancreaticobiliary maljunction and gallbladder carcinoma: meta-analysis. Hepatobiliary Pancreat Dis Int. 2011;10:570–80.

    Article  PubMed  Google Scholar 

  9. Kusano T, Takano T, Tachibana K, Tanaka Y, Kamachi M, Ikematsu Y, et al. Whether or not prophylactic excision of the extrahepatic bile duct is appropriate for patients with pancreaticobiliary maljunction without bile duct dilatation. Hepato-Gastroenterology. 2005;52:1649–53.

    PubMed  CAS  Google Scholar 

  10. Ohuchida J, Chijiiwa K, Hiyoshi M, Kobayashi K, Konomi H, Tanaka M. Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation. Arch Surg. 2006;141:1066–70.

    Article  PubMed  Google Scholar 

  11. Funabiki T, Matsubara T, Miyakawa S, Ishihara S. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbeck's Arch Surg. 2009;394:159–69.

    Article  Google Scholar 

  12. Seki M, Yanagisawa A, Ninomiya E, Ninomiya Y, Ohta H, Saiura A, et al. Clinicopathology of pancreaticobiliary maljunction: relationship between alterations in background biliary epithelium and neoplastic development. J Hepato-Biliary-Pancreat Surg. 2005;12:254–62.

    Article  Google Scholar 

  13. Matsubara T, Sakurai Y, Zhi L, Miura H, Ochai M, Funabiki T. K- ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction. J Hepato-Biliary-Pancreat Surg. 2002;9:312–21.

    Article  Google Scholar 

  14. Yamada S, Shimada M, Utsunomiya T, Morine Y, Imura S, Ikemoto T, et al. Hilar cholangiocarcinoma accompanied by pancreaticobiliary maljunction without bile duct dilatation 20 years after cholecystectomy: report of a case. J Med Investig. 2013;60:169–73.

    Article  Google Scholar 

  15. Ando H, Ito T, Nagaya M, Watanabe Y, Seo T, Kaneko K. Pancreaticobiliary maljunction without choledochal cysts in infants and children: clinical features and surgical therapy. J Pediatr Surg. 1995;30:1658–62.

    Article  CAS  PubMed  Google Scholar 

  16. Kamisawa T, Ando H, Suyama M, Shimada M, Morine Y, Shimada H. Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol. 2012;47:731–59.

    Article  PubMed  Google Scholar 

  17. Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, et al. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepato-Biliary-Pancreat Surg. 2015;22:249–73.

    Article  Google Scholar 

  18. Kamisawa T, Ando H, Shimada M, Hamada Y, Itoi T, Takayashiki T, et al. Recent advances and problems in the management of pancreaticobiliary maljunction: feedback from the guidelines committee. J Hepatobiliary Pancreat Sci. 2014;21:87–92.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayuki Ohtsuka .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Takayashiki, T., Yoshitomi, H., Furukawa, K., Ohtsuka, M. (2018). Therapeutic Strategy for PBM Without Biliary Dilatation. In: Kamisawa, T., Ando, H. (eds) Pancreaticobiliary Maljunction and Congenital Biliary Dilatation. Springer, Singapore. https://doi.org/10.1007/978-981-10-8654-0_27

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-8654-0_27

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-8653-3

  • Online ISBN: 978-981-10-8654-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics